AI Insight
The healthcare system excels at prescribing medications but lacks adequate support and guidance for stopping them. Clinical trials typically focus on short-term use, leaving insufficient evidence about long-term effects or appropriate discontinuation protocols. This gap particularly affects antidepressants, opioids, beta-blockers, and other commonly prescribed drugs, where patients struggle to stop medication with little medical guidance, sometimes leading to prescription cascades where additional drugs are prescribed to manage side effects.
Why it matters
The absence of deprescribing protocols leaves patients without support when discontinuing medications, potentially causing withdrawal symptoms and other complications. This systemic gap affects millions taking long-term medications and contributes to problems like opioid dependency and polypharmacy, particularly in elderly populations managing multiple conditions.
Understand the Science
Modern medicine has an impressive array of drugs in its arsenal. If you are unwell, there is a very good chance your doctor will prescribe a pill to get you back to health. What our medical system is less good at, however, is stopping medication.
Take antidepressants. The drugs aren’t effective for everyone, but they work well for some. Once the medication does its job, though, or the life circumstances that brought on depression grow easier – what then? We don’t yet have a good answer.
Because antidepressants are relatively safe drugs, they can often be dispensed for months or years on end, without much consideration about the long-term implications, as we discuss. But thousands of people struggle to stop taking them, with little help from doctors.
Advertisement
if( window?.adverts?.addToArray ) {
window.adverts.addToArray( {
“pos”: “mid-article-slot”
} );
}
The problem starts long before doctors write out the prescription, though. Clinical trials are typically short-term, lasting only a matter of weeks, and there are few financial rewards or even resources for those who want to study long-term use or when medication should be stopped. This lack of evidence then informs clinical guidance – or rather, its absence.
Few industries want to help people stop using their products, but healthcare should
Antidepressants are just one example. The opioid crisis was spawned, in part, by a flippant attitude to prescribing drugs, and a failure to regulate how often physicians should review patients’ doses. Medications from beta-blockers to acid-reducing stomach drugs, though beneficial for heart or stomach issues in the short term, can cause serious long-term problems. When such issues do come up, physicians have a tendency to prescribe more medications to help combat any side effects – a problem known as a “prescription cascade”, which can be especially difficult for people managing health issues later in life.
Few industries are invested in getting people to stop using their products, but healthcare should be an exception. We need to pay attention to the problems that arise when people stop taking medication, and develop detailed guidance and support, so that when it is the right time to make a change, deprescribing is a valid option, too.
Source: The healthcare industry isn’t built for coming off medication